michael diaz, md, considers what pbms can do to help community oncology
Published 6 years ago • 7 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:43
michael diaz, md, talks about why the community oncology setting is the best value for patients
-
1:01
michael diaz, md, discusses what cancer patients can do to advocate for themselves
-
1:06
michael diaz, md, on how community oncology is shaping the future of cancer care
-
1:17
michael diaz, md, shares what coa is doing to educate cancer care patients
-
1:36
dr michael diaz outlines important lessons learned from the ocm
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
2:17
mrd: a promising biomarker in multiple myeloma
-
3:03
get to know: jeffrey suppinger, m.d., family medicine
-
1:32
dr michael diaz explains challenges to capturing electronic patient reported outcomes
-
1:13
the importance of cd47 as a target in mds and aml
-
0:21
brian bunkers, m.d., family medicine - mayo clinic health system
-
2:53
meet ben heyman, md: hematologist
-
1:23
jeffrey weber, md, phd discusses the long term side effects with immunotherapies
-
1:59
chad m. teven, md
-
1:06
the impact of bmi on the outcomes of patients with all
-
1:01
david j. mcconkey, phd, on treating bladder cancer with checkpoint inhibitors
-
1:51
dan popescu, md – lehigh valley health network hematology oncology
-
5:58
what myeloma patients need to know about bispecific antibodies
-
1:11
should we be focusing on treating mm?
-
2:27
robert fontana, md - video profile
-
1:16
the importance of multidisciplinary collaboration in the classification of lymphomas
-
17:12
explaining multidisciplinary and complementary care